Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
By Birgit Luber, Joëlle Deplazes, Gisela Keller, Axel Walch, Sandra Rauser, Martin Eichmann, Rupert Langer, Heinz Höfler, Susanna Hegewisch-Becker, Gunnar Folprecht, Ewald Wöll, Thomas Decker, Esther Endlicher, Sylvie Lorenzen, Falko Fend, Christian Peschel and Florian Lordick
Publisher: Springer Nature
Year: 2011
DOI identifier: 10.1186/1471-2407-11-509
OAI identifier:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the
following location(s):
http://link.springer.com/conte... (external
link)
https://bmccancer.biomedcentra... (external
link)
CORE
